Dr Peter A Senior

Type 1 Diabetes & Clinical Islet Transplant Friendocrinologist,
Director, Alberta Diabetes Institute
Charles A. Allard Chair in Diabetes Research

[Dr Peter A Senior @IsletTx]

@doreen_rabi @DiabetesCanada @AliceYYCheng @DianaSherifali And our inclusion of adjunctive therapies for T1D - to help achieve goals important for pwT1D - continues this theme. Importantly providing unified recommendations for T1D across the lifespan starts the journey of bridging the chasm between adult and pediatric care

[Dr Peter A Senior @IsletTx]

@sciqst That will take more than 140 characters. Lots to do not least changing perspectives on risks of T1D and challenging assumptions around the risks of IS

[Dr Peter A Senior @IsletTx]

Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | New England Journal of Medicine https://t.co/MbyjtnYA2z

Hope this proves as transformative as the Edmonton Protocol

[Dr Peter A Senior @IsletTx]

Delighted that @JasmineMaghera is the featured artist at #DDATA2025 from @AlbertaDiabetes

[Dr Peter A Senior @IsletTx]

Excited to present at #ddata2025 on the future of cell therapies for #T1D
Also on the agenda discussion re GLP1 in T1D @DiabetesCanada has CPGs recommending adjunctive therapy

[Dr Peter A Senior @IsletTx]

Nerea Cuesta-Gomes presenting at ⁦#ipita2025 in Pisa. Excellent post-doc scientist ⁦@AlbertaDiabetes⁩ ⁦@UAlberta_FoMD⁩

[Dr Peter A Senior @IsletTx]

Jamie Boisvenue, Class of '25 | Department of Medicine https://t.co/1GdntGmDmq

[Dr Peter A Senior @IsletTx]

Congrats Farid and colleagues. I was delighted to chair the DSMB and can attest to the rigorous conduct of the study - and the very impressive safety is hugely important

[Daniel J Drucker @DanielJDrucker]

New over 22 weeks dapagliflozin, as an adjunct to insulin, in youth with #T1D reduced measured eGFR (mGFR) improved glycemic control and was safe when combined with ketone testing and risk mitigation strategies @UHN @NatureMedicine https://t.co/XlAHq8ZOdN @uoftmedicine

[Dr Peter A Senior @IsletTx]

U of A celebrates 25th anniversary of the Edmonton Protocol, advancing diabetes treatment | CityNews Edmonton https://t.co/FZDQWEl3um

[Dr Peter A Senior @IsletTx]

Thanks to ⁦@GairdnerAwards⁩ and ⁦@ADFDiabetes⁩ for supporting our 2 day event. ⁦@UAlberta_FoMD⁩ ⁦@AlbertaDiabetes⁩

[Dr Peter A Senior @IsletTx]

So excited to hear about Hypoimmune islet transplants from Sonja Schrepfer from Sana Biotechnology - without immunosuppression
Is this the future for cell therapy in diabetes?
@AlbertaDiabetes #25EP celebrating the 25th anniversary of the Edmonton Protocol

[Dr Peter A Senior @IsletTx]

Congrats ⁦@EdmontonOilers⁩ OT win. Glad our celebrations ⁦@AlbertaDiabetes⁩ were not very in time for us to see the win! ⁦@UAlberta⁩

[Dr Peter A Senior @IsletTx]

One more sleep

[Dr Peter A Senior @IsletTx]

Delighted to host a tour of ⁦@RebeccaLHull⁩ lab for ⁦@GiveToUHF⁩ at the ⁦@AlbertaDiabetes⁩

[Dr Peter A Senior @IsletTx]

If you want to hear the who, what, why and how behind CPGs recommending Automated Insulin Delivery and Adjunctive Therapies in #T1D - this is for you!
If you can't make it we will be presenting live in Western Canada, and virtually over the next few months - stay tuned

[iMedicus @iMedicus_ca]

📢 Join us June 9 in Mississauga for the T1D Guideline Update 2025! Register now at https://t.co/E7PHUO54wb

✔️ New insights from the 2025 @DiabetesCanada guidelines
✔️ AID systems, adjunctive therapies, practical tools & more
✔️ Expert Speakers: Dr. Ilana Halperin, Ms. Alanna Chambers, & Dr. Peter Senior

#T1D #DiabetesCare #AIDsystems #ClinicalEducation
This program is recognized by Diabetes Canada.

[Dr Peter A Senior @IsletTx]

@AlbertaDiabetes is recruiting people with #T1D who still have some beta cells left (still have detectable c-peptide). We have a quick prescreening consent for bloodwork to check if that might be you. interested?
https://t.co/gR1FZMDRr4

[UAlberta Med & Dent @UAlberta_FoMD]

Join the diabetes research community on June 5 at the @AlbertaDiabetes and @GairdnerAwards Scientific Symposium as part of the 25th anniversary celebrations of the Edmonton Protocol.

This exciting event will include sessions on beta cell replacement therapy, immune responses and islet cell biology, along with a panel discussion on future research priorities.

If you’re a researcher, clinician or trainee interested in diabetes research, we’d love to see you there.

Happening 8:30 a.m. - 4:30 p.m. at the University of Alberta’s Telus International Centre.

Reserve your spot: https://t.co/WBqvJZaHub

[Dr Peter A Senior @IsletTx]

Excited to enroll our first participant for testing an agent (tolimidone) we hope will promote beta cell regeneration, building on preclinical work from Dr Jean Buteau at @AlbertaDiabetes . Supported by Alberta Diabetes Foundation & @biodexa_pharma https://t.co/qvP9KfBuuS

[Dr Peter A Senior @IsletTx]

Hope you can join us on Tuesday 20th at 7.30 Eastern

[The Canadian Journal of Diagnosis @cjdiagnosis]

Join us for The Best of ATTD Webinar as Canadian experts share key insights from the 2025 conference on the latest in diabetes technology and care. Scan the QR code or use the link to register now: https://t.co/GWVm1RNa6E
@AkshayJainEndo @IsletTx

[Dr Peter A Senior @IsletTx]

Excited to be part of this process. ⁦@AlbertaDiabetes⁩ Medical Affairs team hosts international islet cell therapy workshops https://t.co/dA9jOZiHa6